Jump to content

Hydrocodone/guaifenesin

From Wikipedia, the free encyclopedia

Hydrocodone/guaifenesin
Combination of
HydrocodoneOpioid agonist
GuaifenesinExpectorant
Clinical data
Trade namesObredon, Flowtuss, others
AHFS/Drugs.com
License data
Routes of
administration
By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
KEGG

Hydrocodone/guaifenesin, sold under the brand name Obredon among others, is a fixed-dose combination medication used for the treatment of cough.[2] It contains hydrocodone, as the bitartrate, an opioid agonist; and guaifenesin, an expectorant.[2] It is taken by mouth.[2]

Hydrocodone/guaifenesin was approved for medical use in the United States in 2014.[3][4]

Adverse effects

[edit]

In the US, the label for hydrocodone/guaifenesin contains a black box warning about addiction, abuse, and misuse.[2]

References

[edit]
  1. ^ "Flowtuss (hydrocodone bitartrate and guaifenesin) oral solution, CII Initial U.S. Approval: 2014". DailyMed. Retrieved 21 December 2023.
  2. ^ a b c d e "Obredon- hydrocodone bitartrate and guaifenesin solution". DailyMed. 15 December 2023. Retrieved 21 December 2023.
  3. ^ "Flowtuss, (hydrocodone bitartrate and guaifenesin), oral solution". U.S. Food and Drug Administration (FDA). 29 February 2016. Retrieved 21 December 2023.
  4. ^ "Obredon, (hydrocodone/guaifenesin) Oral Solution". U.S. Food and Drug Administration (FDA). 7 April 2015. Retrieved 21 December 2023.